BUTALBITAL |
ITOBARBITAL |
TETRALLOBARBITAL |
SANDOPTAL |
BUTALBITAL CIII |
ALISOBUMAL |
ALLYLBARBITURIC ACID |
5-ALLYL-5-(2-METHYLPROPYL)BARBITURIC ACID |
5-ALLYL-5-(2'-METHYL-N-PROPYL) BARBITURIC ACID |
5-ALLYL-5-ISOBUTYL-2,4,6(1H,3H,5H)-PYRIMIDINETRIONE |
ISO-BUTYLALLYLBARBITURIC ACID |
ALLYLBARBITONE |
BUTALBARBITAL |
BUTALBITALUM |
5-(2-METHYLPROPYL)-5-PROP-2-ENYL-1,3-DIAZINANE-2,4,6-TRIONE |
5-ISOBUTYL-5-ALLYLBARBITURIC ACID |
5-ALLYL-5-ISOBUTYLBARBITURIC ACID |
5-ALLYL-5-ISOBUTYL-PYRIMIDINE-2,4,6-TRIONE |
ALLYLBARBITAL |
pubchem.compound:2481 |
rxcui:19860 |
chemidplus:77-26-9 |
chembl:CHEMBL454 |
drugbank:00241 |
FDA Approval | not approved by the FDA |
Drug Class | small molecule |
Drug Indications | Analgesics |
Year of Approval | not approved by the fda |
Drug Class | analgesics |
antagonist (inhibitory) |
Novel drug target | Established target |
Trial Name | - |
antagonist (inhibitory) |
Trial Name | - |
Novel drug target | Established target |
antagonist (inhibitory) |
Trial Name | - |
Novel drug target | Established target |
positive modulator (activating) |
potentiator |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
Trial Name | - |
antagonist (inhibitory) |
Trial Name | - |
Novel drug target | Established target |
positive modulator (activating) |
potentiator |
Novel drug target | Established target |
Trial Name | - |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
positive modulator (activating) |
potentiator |
Trial Name | - |
Novel drug target | Established target |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
positive modulator (activating) |
potentiator |
Novel drug target | Established target |
Trial Name | - |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
positive modulator (activating) |
potentiator |
Trial Name | - |
Novel drug target | Established target |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
positive modulator (activating) |
potentiator |
Trial Name | - |
Novel drug target | Established target |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
positive modulator (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
positive modulator (activating) |
Direct Interaction | yes |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
positive modulator (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
positive modulator (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
positive modulator (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
positive modulator (activating) |
Direct Interaction | yes |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
positive modulator (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
positive modulator (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
positive modulator (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
positive modulator (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
BUTALBITAL | Primary Drug Name |
Drug Class | analgesics |
Year of Approval | not approved by the fda |
Drug Indications | Analgesics |
Drug Class | small molecule |
FDA Approval | not approved by the FDA |
D05BQK | TTD Drug ID |